FDA Approved: GOCOVRI — Original Application (Adamas Pharma, LLC)

View source ↗

Summary

FDA approved GOCOVRI (amantadine) extended-release for the treatment of dyskinesia in patients with Parkinson's disease who are on levodopa therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Gocovri (amantadine extended-release)

Snippet

ORIG AP for GOCOVRI (AMANTADINE)